P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS

• Nico Gagelmann,
• Vikas Gupta,
• Donal P Mclornan,
• Prithviraj Bose,
• Pankit Vachhani,
• Haifa Kathrin Al-Ali,
• Haris Ali,
• Philipp Treskes,
• Sarah Buckley,
• Karisse Roman-Torres,
• Bart Scott

Affiliations

Nico Gagelmann

1 University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany

Vikas Gupta

2 Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Donal P Mclornan

3 University College London Hospitals, NHS Foundation Trust, London, United Kingdom

Prithviraj Bose

4 The University of Texas MD Anderson Cancer Center, Houston, United States

Pankit Vachhani

5 O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, United States

Haifa Kathrin Al-Ali

6 Krukenberg Cancer Center, University Hospital Halle, Halle, Germany

Haris Ali

7 City of Hope, Hematology and Hematopoetic Cell Transplantation, Duarte, United States

Philipp Treskes

8 IQVIA CSMS Germany GmbH, Mannheim, Germany

Sarah Buckley

9 CTI BioPharma Corp., Seattle, United States

Karisse Roman-Torres

9 CTI BioPharma Corp., Seattle, United States

Bart Scott

10 Fred Hutchinson Cancer Center, Seattle, United States